For: | Wang JF, Lu HD, Wang Y, Zhang R, Li X, Wang S. Clinical characteristics and prognosis of non-small cell lung cancer patients with liver metastasis: A population-based study. World J Clin Cases 2022; 10(30): 10882-10895 [PMID: 36338221 DOI: 10.12998/wjcc.v10.i30.10882] |
---|---|
URL: | https://www.wjgnet.com/2307-8960/full/v10/i30/10882.htm |
Number | Citing Articles |
1 |
Chase J. Wehrle, Noah X. Tocci, Keyue Sun, Chunbao Jiao, Hanna Hong, Abby Gross, Erlind Allkushi, Melis Uysal, Maureen Whitsett Linganna, Katheryn Stackhouse, Koji Hashimoto, Andrea Schlegel, R. Matthew Walsh, Charles Miller, David C. H. Kwon, Federico Aucejo. Utility of circulating tumor DNA in secondary liver malignancies: What we know and what is to come. Journal of Surgical Oncology 2024; doi: 10.1002/jso.27838
|
2 |
Yomna M. Nassar, Francis Williams Ojara, Alejandro Pérez-Pitarch, Kimberly Geiger, Wilhelm Huisinga, Niklas Hartung, Robin Michelet, Stefan Holdenrieder, Markus Joerger, Charlotte Kloft. C-Reactive Protein as an Early Predictor of Efficacy in Advanced Non-Small-Cell Lung Cancer Patients: A Tumor Dynamics-Biomarker Modeling Framework. Cancers 2023; 15(22): 5429 doi: 10.3390/cancers15225429
|
3 |
Ruben Geevarghese, Henry Kunin, Elena N. Petre, Rebecca Deng, Samagra Jain, Vlasios S. Sotirchos, Ken Zhao, Constantinos T. Sofocleous, Stephen B. Solomon, Etay Ziv, Erica Alexander. Microwave Ablation of Refractory Oligometastatic Non–Small Cell Lung Cancer in the Liver. Journal of Vascular and Interventional Radiology 2025; 36(2): 266 doi: 10.1016/j.jvir.2024.10.017
|
4 |
Ying Xiong, Feifei Gu, Jin Cui, Yuting Liu, Min Sun, Xinyue Gu, Luhui Zhong, Kai Zhang, Li Liu. Construction and validation of a novel prognostic nomogram for predicting overall survival in lung adenocarcinoma patients with different patterns of metastasis. Journal of Cancer Research and Clinical Oncology 2023; 149(16): 15039 doi: 10.1007/s00432-023-05288-8
|
5 |
Danainut Naratornsirakul, Busyamas Chewaskulyong, Sarawut Kongkarnka, Songporn Oranratnachai. Comparison of treatment outcome between first‐line combination immunotherapy (anti‐PD‐L1 or anti‐PD1) with or without chemotherapy and chemotherapy alone in advanced non‐small cell lung cancer patients in tertiary care hospital. Cancer Medicine 2024; 13(14) doi: 10.1002/cam4.70007
|
6 |
Jun Zhao, Jia Zhong, Yujie Chen, Zipei Chen, Huan Yin, Yuange He, Rongrong Chen, Renhua Guo. Molecular features of NSCLC patients with liver metastasis. Therapeutic Advances in Medical Oncology 2024; 16 doi: 10.1177/17588359241275421
|